ArticleOncology and therapy2024

Correction: Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.

Giulio Metro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.